Data integrity is key to the success of any cell therapy program. CDMOs can implement robust data management systems for ...
Biotechnology company Bracco Imaging announced its expansion into the cell-therapy manufacturing space, establishing a new ...
Cellares, which last year became the first company to receive the FDA's new advanced manufacturing technology designation, ...
Raw materials play a critical role in cell therapy manufacturing. Choosing suboptimal materials at any stage of development ...
Cell therapy, one of the most promising frontiers in modern medicine, holds the potential to cure once-incurable diseases such as cancer and genetic disorders. But for all its promise, manufacturing ...
Cellares. Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the ...
Bracco Imaging is expanding into the cell therapy space to explore new applications of its long-established microbubble technology.
The AMT designation gives Cellares’ clients using the Cell Shuttle priority review with the FDA leading to accelerated regulatory filings SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the ...
CaseBioscience® announces the launch of CaseCryo® CTG DMSO , a next-generation cryopreservation solution developed to support ...
Introducing cell therapy--grade cryopreservation and hypothermic storage solutions designed for consistency, quality, and performance across cell therapy workflows ST. PETERSBURG, Fla., Feb. 6, 2026 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results